Jinlong Y. Lu

Jinlong Y. Lu

Auto-generated profile, based on publicly available information

Jinlong Y. Lu

Department of Biology, University of Rochester, Rochester, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2024 in PNAS Nexus
Verified
Journal Article
Open access
VGVadim N Gladyshev
Vadim N Gladyshev
BABenjamin Anderson
Benjamin Anderson
HBHanna Barlit
Hanna Barlit
BBBenjamin Barré
Benjamin Barré
SBSamuel Beck
Samuel Beck
AZAlex Zhavoronkov
Alex Zhavoronkov
To gain insight into how researchers of aging perceive the process they study, we conducted a survey among experts in the field. While highlighting some common features of aging, the survey exposed broad disagreement on the foundational issues. What is aging? What causes it? When does it begin? What constitutes rejuvenation? Not only was there no consensus on these and other core questions, but none of the questions received a majority opinion—even regarding the need for consensus itself. Despite many researchers believing they understand aging, their understanding diverges considerably. Importantly, as different processes are labeled as “aging” by researchers, different experimental approaches are prioritized. The survey shed light on the need to better define which aging processes this field should target and what its goals are. It also allowed us to categorize contemporary views on aging and rejuvenation, revealing critical, yet largely unanswered, questions that appear disconnected from the current research focus. Finally, we discuss ways to address the disagreement, which we hope will ultimately aid progress in the field.

29 October 2025 in Nature
Verified
Journal Article
Open access
PDF file
DFDenis Firsanov
Denis Firsanov
MZMax Zacher
Max Zacher
XTXiao Tian
Xiao Tian
TSTodd L. Sformo
Todd L. Sformo
YZYang Zhao
Yang Zhao
VGVera Gorbunova
Vera Gorbunova
At more than 200 years, the maximum lifespan of the bowhead whale exceeds that of all other mammals. The bowhead is also the second-largest animal on Earth1, reaching over 80,000 kg. Despite its very large number of cells and long lifespan, the bowhead is not highly cancer-prone, an incongruity termed Peto’s paradox2. Here, to understand the mechanisms that underlie the cancer resistance of the bowhead whale, we examined the number of oncogenic hits required for malignant transformation of whale primary fibroblasts. Unexpectedly, bowhead whale fibroblasts required fewer oncogenic hits to undergo malignant transformation than human fibroblasts. However, bowhead whale cells exhibited enhanced DNA double-strand break repair capacity and fidelity, and lower mutation rates than cells of other mammals. We found the cold-inducible RNA-binding protein CIRBP to be highly expressed in bowhead fibroblasts and tissues. Bowhead whale CIRBP enhanced both non-homologous end joining and homologous recombination repair in human cells, reduced micronuclei formation, promoted DNA end protection, and stimulated end joining in vitro. CIRBP overexpression in Drosophila extended lifespan and improved resistance to irradiation. These findings provide evidence supporting the hypothesis that, rather than relying on additional tumour suppressor genes to prevent oncogenesis3,4,5, the bowhead whale maintains genome integrity through enhanced DNA repair. This strategy, which does not eliminate damaged cells but faithfully repairs them, may be contributing to the exceptional longevity and low cancer incidence in the bowhead whale.

3 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
FAFathima Athar
Fathima Athar
ZZZhizhong Zheng
Zhizhong Zheng
SRSebastien Riquier
Sebastien Riquier
MZMax Zacher
Max Zacher
JLJ. Yuyang Lu
J. Yuyang Lu
VGVera Gorbunova
Vera Gorbunova
Several bat species live >20–40 years, suggesting that they possess efficient anti-aging and anti-cancer defenses. Here we investigate the requirements for malignant transformation in primary fibroblasts from four bat species Myotis lucifugus, Eptesicus fuscus, Eonycteris spelaea, and Artibeus jamaicensis – spanning the bat evolutionary tree and including the longest-lived genera. We show that bat fibroblasts do not undergo replicative senescence, express active telomerase, and show attenuated SIPs with dampened secretory phenotype. Unexpectedly, unlike other long-lived mammals, bat fibroblasts are readily transformed by two oncogenic “hits”: inactivation of p53 or pRb and activation of HRASG12V. Bat fibroblasts exhibit increased TP53 and MDM2 transcripts and elevated p53-dependent apoptosis. M. lucifugus shows a genomic duplication of TP53. We hypothesize that some bat species have evolved enhanced p53 activity as an additional anti-cancer strategy, similar to elephants. Further, the absence of unique cell-autonomous tumor suppressive mechanisms may suggest that in vivo bats may rely on enhanced immunosurveillance.

27 November 2024 in Nature Aging
Verified
Journal Article
Open access
PDF file
FMFrancesco Morandini
Francesco Morandini
JLJinlong Y. Lu
Jinlong Y. Lu
CRCheyenne Rechsteiner
Cheyenne Rechsteiner
ASAladdin H. Shadyab
Aladdin H. Shadyab
RCRamon Casanova
Ramon Casanova
VGVera Gorbunova
Vera Gorbunova
Transposable elements (TEs) are DNA sequences that expand selfishly in the genome, possibly causing severe cellular damage. While normally silenced, TEs have been shown to activate during aging. DNA 5-methylcytosine (5mC) is one of the main epigenetic modifications by which TEs are silenced and has been used to train highly accurate age predictors. Yet, one common criticism of such predictors is that they lack interpretability. In this study, we investigate the changes in TE 5mC methylation that occur during aging in human blood using published methylation array data. We find that evolutionarily young long interspersed nuclear elements 1 (L1s), the only known TEs capable of autonomous transposition in humans, undergo the fastest loss of 5mC methylation, suggesting an active mechanism of de-repression. The same young L1s also showed preferential gain in chromatin accessibility but not expression. The long terminal repeat retrotransposons THE1A and THE1C also showed very rapid 5mC loss. We then show that accurate age predictors can be trained on both 5mC methylation of individual TE copies and average methylation of TE families genome wide. Lastly, we show that while old L1s gradually lose 5mC during the entire lifespan, demethylation of young L1s only happens late in life and is associated with cancer.

28 November 2025 in Nature
Verified
Journal Article
Open access
PDF file
DFDenis Firsanov
Denis Firsanov
MZMax Zacher
Max Zacher
XTXiao Tian
Xiao Tian
TSTodd L. Sformo
Todd L. Sformo
YZYang Zhao
Yang Zhao
VGVera Gorbunova
Vera Gorbunova